BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:[Cancer Research Institute Technology Impact Award | Research fund
 ing ]
DTSTART;VALUE=DATE:20211115
DTSTAMP:20260428T021241Z
UID:af8c0e09d2ba528caa813b5a24c242effe41804dc0c762efed81de27
CATEGORIES:Call for proposal
DESCRIPTION:Aim\n\nTo address the gap between technology development and c
 linical application of cancer immunotherapies. These grants aim to encoura
 ge collaboration between technology developers and clinical cancer immunol
 ogists and to generate the proof-of-principle of a novel platform technolo
 gy in bioinformatics\, ex vivo or in silico modeling systems\, immunologic
 al or tumor profiling instrumentation\, methods\, reagents and assays\, or
  other relevant technologies that can enable clinician scientists to gener
 ate deeper insights into the mechanisms of action of effective or ineffect
 ive cancer immunotherapies.\n\nCRI Technology Impact Award \n\nAvailable f
 unding\n\nTechnology Impact Awards provide up to $100\,000 per year for tw
 o years. The funds may be used for salary\, technical assistance\, supplie
 s\, capital equipment\, or scientific travel. CRI does not provide funds f
 or indirect costs. Payments are made quarterly in U.S. currency to the hos
 t institution.\n\nRequirements / Eligibility\n\n	Applicants must hold a fa
 culty appointment as a tenure-track assistant professor (or higher rank) a
 t the time of award activation. If not\, documentation from their institu
 tion must accompany the Letter of Intent indicating they will hold the p
 osition of assistant professor (or higher rank) by the time of award activ
 ation.\n	The grant will be awarded to a scientist who describes an extraor
 dinarily novel\, yet practical research plan that is creative and technica
 lly sophisticated.\n	Joint submissions from collaborators will also be con
 sidered. (The collaborators will share the award.) Each collaborator must 
 meet the eligibility criteria.\n\nSelected projects that meet their 12 and
  24 month milestones may be eligible for follow-on funding that will enabl
 e the established proof-of-concept technology to be developed into a metho
 dology that improves cancer immunotherapy research worldwide.\n\nHow to ap
 ply\n\nLetters of intent must be submitted electronically. Once you access
  the application\, you will be asked to create a user account unique to yo
 u\, which will catalogue all applications you submit to CRI. If you have s
 ubmitted a grant application to CRI in the past\, please login with your e
 xisting user account.\nThe link to the application portal is located in th
 e CRI Technology Impact Award Call for Proposals link above.\n\nFor Furthe
 r Information\n\nContact the Research Office if you have questions or conc
 erns\, or if you decide to submit a letter of intent.\n 
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR